Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. - Wikidata - wikimedia - TriplyDB

Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.

Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.

http://www.wikidata.org/entity/Q36140458

about

Noble metals in oncology Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications Multifunctional gold nanoparticles for diagnosis and therapy of disease Gold nanoparticles - the theranostic challenge for PPPM: nanocardiology application.Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.Development and applications of radioactive nanoparticles for imaging of biological systems.The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors.EGCG in Green Tea Induces Aggregation of HMGB1 Protein through Large Conformational Changes with Polarized Charge Redistribution.Reading the tea leaves of tumor-mediated immunosuppression.Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology Radio-nanomaterials for biomedical applications: state of the art Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.Nanoformulation of natural products for prevention and therapy of prostate cancer.Catechin-capped gold nanoparticles: green synthesis, characterization, and catalytic activity toward 4-nitrophenol reduction.Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment.Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy.Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy.Molecular Imaging in Nanotechnology and Theranostics.Nanoparticles and radiotracers: advances toward radionanomedicine Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities.Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interaction.Tactics for preclinical validation of receptor-binding radiotracers.Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.Combined Positron Emission Tomography and Cerenkov Luminescence Imaging of Sentinel Lymph Nodes Using PEGylated Radionuclide-Embedded Gold Nanoparticles.Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems Theranostic Gold Nanoantennas for Simultaneous Multiplexed Raman Imaging of Immunomarkers and Photothermal Therapy Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy.Mangiferin functionalized radioactive gold nanoparticles (MGF-198AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy.

P2860

Q26777745-03464498-A1CE-478E-8201-0C9F714A9B9F Q28074448-258F006E-CC50-435B-9A26-04F73202D859 Q30442090-799AA7B1-7764-4300-A64E-CFCE7C5AFAB4 Q30452438-06B6B549-56E9-4C94-AF76-E88C1E39F1BD Q30461227-26A926BB-80E6-4308-96A6-16B0BCB84E4E Q33610434-6E7DE408-620D-4822-AF44-E3388146BF02 Q33845027-208CA0A5-3313-4A86-B8B6-46B710C2EB6E Q34104295-B7679ABB-9A7B-48B9-942C-7566383E574B Q34437253-ED7205D6-D239-4590-84DE-09F9ACD4AB8A Q35291689-D3E99243-63C2-4396-B32F-84B87447375B Q35814479-E9C03B3D-073A-4DF2-9D0A-214E716519AA Q36555361-EFC94F41-BB71-4290-BBF5-77C5FCDE444E Q36602639-E0E80593-EBBC-4727-8018-D1BDD11E6E20 Q36675075-2599727E-2B3C-46FB-8D88-19CB337899E3 Q37116964-85CBE6E7-B95C-4CD7-AA26-6441D58D14ED Q37131224-7716D7AA-A287-460D-B0FD-12D41334FCC0 Q37198232-B7DC6B4F-1E12-445B-8C9A-51BA671AB625 Q37473193-9FDBDF57-E844-41D3-A513-BC81CD7E548F Q37621520-371F29BB-9DC5-4FAE-83B5-9BB1BFE400BB Q37624164-4CA4F945-6787-4A53-A6C1-707E296092C4 Q38137746-D4128C86-1101-4C22-9006-125D6FC32FD0 Q38140631-655F72D7-1CB3-4D83-B267-1D49801018C3 Q38228652-897D0B09-347D-4B07-9A4A-06D44B99B6CA Q38297915-85B71B58-2AA4-4C41-A784-E57E9831D7CF Q38519540-5EBC2268-136C-4066-B813-4B8F8A61F31E Q38584742-046A514D-E680-46BE-BAD5-FC377C4ECEF6 Q38738754-090F0391-0799-4424-9D0F-C449A9DEC114 Q38785806-D22A21D4-0B39-4683-ACCF-E6DD99C8A2D9 Q38789241-FECFDCF0-8B5F-4B39-AFC6-EF3CF12979C5 Q38812845-80BF8A16-A37B-4E25-B7CE-81D41664F215 Q38851914-A2DE401B-18B8-47AD-A05F-1EC0C3CCBF8F Q38943270-2F434801-082C-458C-8B96-97D3D0833123 Q38971012-559C142C-C669-4F8B-A465-4B5BBEDCC0F5 Q38984519-B51CD249-77C9-433E-91F8-D353838016D7 Q39360750-7768FC35-0847-4D1D-8C38-086FB5D7212E Q39579062-1D4EFE66-19EF-43F9-8900-652A363686C4 Q41169121-04B05648-2DB4-48D9-B10E-88EA5E59BCA9 Q41194394-01C6513B-0CB1-48EF-A022-D867D36E945F Q45986152-D1D6F44E-687F-4345-AFC5-F8FFB1E7DC8E Q50203117-C76FDED8-05B3-4ACB-BC51-41ABADE6780A

P2860

Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.

http://www.wikidata.org/entity/Q36140458

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Laminin receptor specific ther ...... y in treating prostate cancer.

@ast

Laminin receptor specific ther ...... y in treating prostate cancer.

@en

type

label

Laminin receptor specific ther ...... y in treating prostate cancer.

@ast

Laminin receptor specific ther ...... y in treating prostate cancer.

@en

prefLabel

Laminin receptor specific ther ...... y in treating prostate cancer.

@ast

Laminin receptor specific ther ...... y in treating prostate cancer.

@en

P1433

Q36140458-53DC051D-FB2B-4543-BE39-EA9C3C01D220

P1476

Q36140458-E11EC20B-EC23-424D-8C8B-AAC909EDC903

P2093

Q36140458-0F372276-F73C-47A4-A134-9553ED84B6A1

Q36140458-296E180B-9246-4F51-A270-C4F666912C5D

Q36140458-2A574B97-3B07-4B6A-8F28-5E5F5E02F0F1

Q36140458-32377362-268C-462B-9BAB-5B520D3C3FBB

Q36140458-394412D4-4D58-47C1-9422-8AB908271396

Q36140458-3D416DD9-E6A7-4BAB-B09A-B3DA20FA984B

Q36140458-457505BC-DE20-4CCC-97D4-05CF470DF7D3

Q36140458-48DBE576-76A4-496A-87F2-EFA7E56692A4

Q36140458-4FD65EB3-9B41-45CA-8E49-974B4E500A7F

Q36140458-535EC39D-2F35-47AE-8A6F-1590545B5003

P2860

Q36140458-04540DEB-327D-4392-A82B-64FC81B4B5F5

Q36140458-064D5AF8-6637-46FA-BEA8-C691DB93F69C

Q36140458-08BA3418-F4C2-409E-A5E0-1714B950CD25

Q36140458-0E1C4AD3-7D04-406B-AAE9-73EE257C8EDA

Q36140458-17445982-5AF5-4EF6-8A0C-21E8E97FB693

Q36140458-187CE244-2324-4E2F-9616-368E7EB9B948

Q36140458-1E66FDF3-2F25-43F7-9C52-4757E31F70F1

Q36140458-356941F8-CEED-49F3-8884-1D8B7A0E202A

Q36140458-422DF4BB-C4CF-4A6F-A5B8-974E77762384

Q36140458-47557410-3C8E-4299-8224-BDA1B64A4395

P304

Q36140458-860369A8-543B-4BCE-9C61-A2FDB2FC3DA2

P31

Q36140458-7FA71F23-FAB6-4EF3-8FA0-20AD693051C9

P356

Q36140458-E4596017-8BD2-4C85-9B26-3523E943BFDF

P407

Q36140458-D16D6B05-04EF-4155-B23F-0F43D02D8462

P433

Q36140458-343BE890-5608-4334-A33B-8905775C24FF

P478

Q36140458-5C16BC44-5A69-4493-AC05-D59D45FBDBDA

P50

Q36140458-019102AF-1DCE-41B4-99BE-C12D705C9F6C

Q36140458-880C4236-B4B2-4D39-932D-8AB248CC6128

P577

Q36140458-63C05CFE-FB4E-4B71-9F1F-1ABD358302AF

P5875

Q36140458-FBAFBC05-1040-4D9C-A2D3-69C8838C8B7A

P698

Q36140458-9D242BD4-0C10-43A3-92A1-6E88D541FCD3

P921

Q36140458-C4BD86E1-A072-4E46-8666-4DA423B4F80F

P932

Q36140458-2EA444FF-9A25-410B-9681-8FAB86DC83AD

P356

PNAS.1121174109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Laminin receptor specific ther ...... cy in treating prostate cancer

@en

P2093

Ajit Zambre

http://www.w3.org/2001/XMLSchema#string

Anandhi Upendran

http://www.w3.org/2001/XMLSchema#string

Cathy S Cutler

http://www.w3.org/2001/XMLSchema#string

Charles Caldwell

http://www.w3.org/2001/XMLSchema#string

Charles Jeffrey Smith

http://www.w3.org/2001/XMLSchema#string

Evan Boote

http://www.w3.org/2001/XMLSchema#string

Hendrik Engelbrecht

http://www.w3.org/2001/XMLSchema#string

J David Robertson

http://www.w3.org/2001/XMLSchema#string

Jatin Vimal

http://www.w3.org/2001/XMLSchema#string

John R Lever

http://www.w3.org/2001/XMLSchema#string

P2860

A receptor for green tea polyphenol EGCG

Isolation of a tumor cell laminin receptor

Screening and prostate-cancer mortality in a randomized European study

Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer.

Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice

Stereotactic body radiotherapy for organ-confined prostate cancer.

Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity.

Recent advances in radiotherapy.

Reduced-order constrained optimization in IMRT planning

Molecular genetics of prostate cancer: new prospects for old challenges

P304

12426-12431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1121174109

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229157299

http://www.w3.org/2001/XMLSchema#string

P698

22802668

http://www.w3.org/2001/XMLSchema#string

P921

P932

3411993

http://www.w3.org/2001/XMLSchema#string